Skip to main content
ZEPP $5.42 +1.12%
ZEPP logo

ZEPP · Zepp Health Corp

Track ZEPP — free
$5.42 +0.06 (+1.12%) At close · Aug 14
Market Cap
$79.48M
Shares
14.66M
All earnings calls

Earnings call · FY2024 Q1

Zepp Health Corp Q1 FY2024 Earnings Call

Zepp Health Corp Q1 FY2024 Earnings Call

Concluded May 20, 2024
May 20, 2024 26 turns
Period
FY2024 Q1
Runtime
Sources
1 artifact

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Helio Ring new product launch 24 Geographic mix and global operations 23 Product portfolio (Balance, Active, Bip, Falcon, T-Rex) 19 Self-branded transformation and product mix 19 Gross margin expansion 15 Seasonality and revenue outlook 8

Management tone

Positive

Net tone +32 · moderate hedging

Grounding quotes
  • “Our gross margin has nearly doubled over the past 2 years, with the recent quarter showing 37% compared to 16% in Q1 2023.”
  • “This gives us an opportunity to realize exponential growth in our revenue in the upcoming peak seasons through our marketing activities.”
  • “Q1 started slowly, we have guided higher for Q2. Q3 and Q4 are typically our high seasons, and last year our total revenue was around $350 million. This year, we expect to range between $200 million to $300 million.”

Forward guidance

2 guided metrics

Management's latest ranges and targets are included below.

Research coverage

1 live source

Switch sources without leaving this page or losing your listening position.

Research materials

Open the source you need; every reader stays inside this workspace.

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Revenue
Q2 2024
$40M – $55M
Total revenue
this year
$200M – $300M
Full-screen source Call document